高清福利片

高清福利片_

Grants to treat alcohol-use disorder and transform cancer diagnosis

22 October 2021

$10 million NHMRC funding

Sydney researchers have received two National Health and Medical Research Council (NHMRC) Synergy Grants worth $10 million.

Two University of Sydney research teams have been awarded NHMRC Synergy Grants to lead projects that will develop treatments for alcohol-use disorder and transform diagnosis of breast and lung cancer.

The Synergy Grants, announced today by the Hon. Greg Hunt MP, support outstanding multidisciplinary teams of investigators to work together to answer major questions that cannot be answered by a single investigator.

Professor Robyn Ward, Executive Dean of the听, congratulated the researchers.

鈥淭he success in securing two synergy grants speaks to the innovative and collaborative nature of the projects.

鈥淏oth teams are tackling significant health problems, with the focus on improving long-term outcomes for patients and their families.鈥

Linking clinical and basic science discovery to find new treatments for alcohol use disorder

笔谤辞蹿别蝉蝉辞谤听Paul Haber听and Associate Professor Kirsten Morleyfrom the Faculty of Medicine and Health听are chief investigators on a project which will deliver new approaches to treat alcohol use disorder, including how to tailor treatment to individual patient characteristics.

鈥淢ore than a million Australians meet criteria for an alcohol use disorder, making it a leading cause of injury, chronic disease and mortality,鈥 said Professor Haber.

鈥淒uring the COVID-19 pandemic we鈥檝e also seen increased consumption of alcohol and hospital admissions from alcohol problems.

鈥淐urrent treatment options have limited effectiveness and there haven鈥檛 been any new medication discoveries for 20 years."

鈥淭his program will allow us to improve the treatment options for this common and disabling disorder by building a large collaborative research network to bridge the gaps between discovery sciences and the clinic," said Associate 笔谤辞蹿别蝉蝉辞谤听Morley.

鈥淲e will identify mechanisms and predictors of efficacy to inform future drug discovery and develop a personalised medicine approach that will improve the lives of many Australians.鈥

Prof Paul Haber听 University of Sydney听
Assoc Prof Kirsten Morley听 University of Sydney听
Prof Andrew Lawrence听 Florey Institute of Neuroscience and Mental Health听
Assoc Prof Victoria Manning听 Monash University听
Prof Daniel Lubman听 Monash University听
Prof Gavan McNally听 University of New South Wales听
Dr Zayra Millan听 University of New South Wales听
Dr Shalini Arunogiri听 Monash University听
Prof Antonio Verdejo-Garcia听 Monash University听
Dr Leigh Walker听 Florey Institute of Neuroscience and Mental Health听
Dr Warren Logge听 Sydney Local Health District听
Dr Rowan Ogeil听 Monash University听
Prof Lorenzo Leggio听 National Institute of Health听
Prof Henry Kranzler听 University of Pennsylvania听
Prof Andrew Baillie听 University of Sydney听
Prof Ronald Grunstein听 University of Sydney听
Dr Christina Perry听 Macquarie University听
Assoc Prof Yvonne Bonomo听 St Vincent鈥檚 Hospital Melbourne听

IMPACT: IMplementation of x-ray PhAse-Contrast Tomography to transform cancer diagnosis

笔谤辞蹿别蝉蝉辞谤听Patrick Brennan, Professor Sarah Lewis and听Dr Amir Tavakoli Taba from the Faculty of Medicine and Health are听chief investigators on a program that will transform diagnosis of breast and lung cancer by establishing a path to clinical implementation of a novel low-dose, high-quality, 3D imaging technique.

鈥淧ropagation-based phase-contrast computed tomography (PB-CT) can improve the imaging signal 10-fold, leading to a considerable improvement in image quality and a substantial reduction in the X-ray dose, compared to conventional X-ray imaging techniques,鈥 said Professor Brennan.

鈥淪uccessful clinical translation of PB-CT requires a multidisciplinary team of experts in academia and beyond. This Synergy Grant allows us to bring together the right people to deliver a world-first PB-CT imaging facility.听

鈥淭he program could revolutionise breast and lung cancer diagnosis worldwide and position Australia as an international hub of scientific, clinical and industrial excellence in X-ray phase-contrast imaging.

鈥淭hrough vastly improved cancer diagnosis and reduced risk and discomfort, PB-CT听has the potential to significantly reduce cancer mortality and morbidity.鈥

Prof Patrick Brennan听 University of Sydney听
Prof Harry Quiney听 University of Melbourne听
Prof Sarah Lewis听 University of Sydney听
Prof Keith Nugent听 Australian National University听
Prof Andrew Peele听 Australian Nuclear Science and Technology Organisation听
Dr Seyedamir Tavakoli Taba听 University of Sydney听
Dr Kaye Morgan听 Monash University听
Ms Jane Fox听 Monash Health听
Mrs Giuliana Tromba听 Elettra Sincrotrone Trieste听
Dr Darren Lockie听 Eastern Health听
Dr Timur Gureyev听 University of Melbourne听
Dr Yakov Nesterets听 CSIRO Manufacturing Flagship听
Dr Christian Dullin听 University Medical Center Gottingen听
Dr Daniel Hausermann听 Australian Synchrotron听
Dr Sheridan Mayo听 CSIRO Manufacturing Flagship听
Dr Matthew Dimmock听 Monash University听

Related news